Abstract Recently, Shvabe AG, a member of the Russian technology international group (Rostec), has developed a carbon composite (CCM) human implant with biomechanical properties. According to experts' assessment, the cost of carbon composite medical devices is only imported...

Recently, Shvabe AG, a member of the Russian technology international group (Rostec), has developed a carbon composite (CCM) human implant with biomechanical properties.

640.jpg

According to experts' assessment, the cost of carbon composite medical devices is only 1/2 to 2/3 of the price of imported metal or ceramic medical devices, while its service life is extended by 3.5-4 times. Commercial production will start after 2022.

In addition to price, carbon composite implants offer a range of superior properties compared to current metal, ceramic and polymer implants widely used in the medical community. In particular, carbon composite implants have higher biocompatibility because all human tissues contain large amounts of carbon.
Oleg Evtushenko, executive director of the famous Rostec state company, said: "As a top priority, Rostec aims to safeguard Russia's national sovereignty and medical security. At present, Rostec has the ability to provide competitive medical devices. We estimate that carbon composite The production facility for materials and medical devices will be completed in 2021-2022."

Aluminum Alloy Plate

Xiaoxian RuiYi Commercial Trade Co.,Limited , https://www.ryaluplate.com